Regeneron Pharmaceuticals (REGN)
Net Income Growth
-6.81%
Quarterly · Period ending:
REGN Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-6.81%period ending
Latest reported-6.81%period ending
REGN Quarterly Net Income YoY % (-37.50% → -6.81%)
Year-over-year change
High-resolution chart · PNG
REGN net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -6.8051% | |
| -10.0779% | |
| -7.9656% | |
| 8.9065% | |
| -2.8416% | |
| 12.0083% | |
| -20.8606% | |
| 33.0224% | |
| 47.9038% | |
| -11.7144% | |
| -3.1326% | |
| -23.402% | |
| 13.6486% | |
| -15.9938% | |
| -46.2943% | |
| -19.391% | |
| -72.5031% | |
| -12.7062% | |
| 93.961% | |
| 93.825% | |
| 245.3583% | |
| 78.5463% | |
| 45.101% | |
| 25.7616% | |
| 364.6815% | |
| 35.4587% | |
| -3.4617% | |
| 12.6031% | |
| -64.9808% | |
| -3.5315% | |
| 372.8012% | |
| 53.1365% | |
| 42.2103% | |
| 92.013% | |
| -31.4466% | |
| 46.6432% | |
| 97.6088% | |
| 50.1973% | |
| 63.3063% | |
| 25.8586% | |
| 0.8092% | |
| 118.0134% | |
| 40.6786% | |
| 163.9212% | |
| 109.8916% | |
| 16.1637% | |
| 13.8111% | |
| -43.5834% | |
| 6.1333% | |
| -33.8117% | |
| -79.4208% | |
| -26.1986% | |
| 13.8553% | |
| 748.631% | |
| 980.2032% | |
| 407.0119% | |
| 222.779% | |
| 126.8166% | |
| -266.1232% | |
| -84.1033% | |
| -145.3678% | |
| -42.3465% | |
| 59.9962% | |
| -3,237.4384% | |
| -70.5315% | |
| -74.601% | |
| -15.7719% | |
| 95.193% | |
| 19.0747% | |
| -50.4648% | |
| -141.1292% | |
| 41.0821% | |
| 31.0562% | |
| 61.1659% | |
| 57.796% | |
| -30.7479% | |
| -13.5646% | |
| -46.7959% | |
| -4.3779% | |
| 20.8992% | |
| 12.6782% | |
| -394.3003% | |
| -1,162.7507% | |
| -212.8566% | |
| -85.5729% | |
| -106.3891% | |
| 114.4088% | |
| 59.5766% | |
| 49.3701% | |
| 314.3208% | |
| 45.712% | |
| 16.5041% | |
| 5.5451% | |
| -18.3337% | |
| -25.777% | |
| -64.648% | |
| -105.0897% | |
| -95.1753% | |
| -191.3852% | |
| -520.7101% |